Table 1.
All | Symptomatic | Asymptomatic | Symptomatic vs asymptomatic p-valueb |
“Fresh” | “Frozen” | “Fresh” vs “frozen” p-valueb |
|
---|---|---|---|---|---|---|---|
Prevalence | 7.2 (5.4–9.3) (51/709) |
11 (6.0–18.1) (13/118) |
6.4 (4.6–8.7) (38/591) |
0.106 | 9.3 (6.1–13.3) (26/281) |
5.8 (3.8–8.5) (25/428) |
0.111 |
Sensitivity | 96.1 (86.5–99.5) (49/51) |
100.0 (75.3–100.0) (13/13) |
94.7 (82.3–99.4) (36/38) |
0.906 | 96.2 (80.4–99.9) (25/26) |
96.0 (79.6–99.9) (24/25) |
0.997 |
Specificity | 97.7 (96.3–98.7) (643/658) |
98.1 (93.3–99.8) (103/105) |
97.6 (96.0–98.7) (540/553) |
0.976 | 96.5 (93.4–98.4) (246/255) |
98.5 (96.8–99.5) (397/403) |
0.854 |
PPV | 76.6 (64.3–86.2) (49/64) |
86.7 (59.5–98.3) (13/15) |
73.5 (58.9–85.1) (36/49) |
0.706 | 73.5 (55.6–87.1) (25/34) |
80.0 (61.4–92.3) (24/30) |
0.824 |
NPV | 99.7% (98.9–100.0) (643/645) |
100.0 (96.5–100.0) (103/103) |
99.6 (98.7–100.0) (540/542) |
0.981 | 99.6 (97.8–100.0) (246/247) |
99.7 (98.6–100.0) (397/398) |
0.989 |
CT, Chlamydia trachomatis; PPV, Positive Predictive Value; NPV, Negative Predictive Value.
Values are percentages (95% confidence intervals) (numbers).
Study prevalence of CT and performance characteristics (sensitivity, specificity, PPV and NPV) were compared between symptomatic and asymptomatic participants and between “fresh” and “frozen” samples using the Pearson Chi-squared test for comparing two proportions.